Functional significance of a putative Sp1 transcription factor binding site in the survivin gene promoter

被引:45
|
作者
Mityaev, M. V. [1 ]
Kopantzev, E. P. [1 ]
Buzdin, A. A. [1 ]
Vinogradova, T. V. [1 ]
Sverdlov, E. D. [1 ]
机构
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
关键词
survivin promoter; regulation of promoter activity; Sp1 binding sites; SNP;
D O I
10.1134/S0006297908110035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We sequenced 1500-bp genomic DNA regions upstream from the survivin gene (BIRC5). DNA was isolated from human placenta and tumors of patients with diagnosed squamous cancer of the lung that showed high-level BIRC5 gene expression. We have revealed four new promoter allelic variants differing in single nucleotide substitutions, one variant with two nucleotide substitutions, and a variant with a TAAA tetranucleotide insertion. All promoter variants displayed low activity in cells with functionally active p53 protein and high activity in cell lines characterized by low level or absence of p53 protein function. The activity of the promoters with single nucleotide substitutions was comparable to that of the wild-type promoter, whereas two nucleotide substitutions markedly reduced the activity. We also demonstrated the functional significance of a putative Sp1 transcription factor-binding site at (-63...-54) upstream from the transcription initiation site. Mutation within this sequence led to a sharp decrease of promoter activity. The functional architecture of the survivin promoter is discussed based on results known from the literature and those obtained here.
引用
收藏
页码:1183 / 1191
页数:9
相关论文
共 50 条
  • [1] Functional significance of a putative Sp1 transcription factor binding site in the survivin gene promoter
    M. V. Mityaev
    E. P. Kopantzev
    A. A. Buzdin
    T. V. Vinogradova
    E. D. Sverdlov
    [J]. Biochemistry (Moscow), 2008, 73 : 1183 - 1191
  • [2] LEUKOSIALIN (CD43) PROMOTER IS THE BINDING-SITE FOR THE TRANSCRIPTION FACTOR SP1
    KUDO, S
    FUKUDA, M
    [J]. FASEB JOURNAL, 1993, 7 (07): : A1221 - A1221
  • [3] A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression
    Hummelshoj, T
    Ryder, LP
    Madsen, HO
    Odum, N
    Svejgaard, A
    [J]. MOLECULAR IMMUNOLOGY, 2006, 43 (07) : 980 - 986
  • [4] A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter
    Liu, WQ
    Innocenti, F
    Wu, MH
    Desai, AA
    Dolan, ME
    Cook, EH
    Ratain, MJ
    [J]. CANCER RESEARCH, 2005, 65 (01) : 46 - 53
  • [5] A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria
    Di Pierro, E
    Cappellini, MD
    Mazzucchelli, R
    Moriondo, V
    Mologni, D
    Poma, BZ
    Riva, A
    [J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (05) : 584 - 591
  • [6] REGULATION OF RAT ORNITHINE DECARBOXYLASE PROMOTER ACTIVITY BY BINDING OF TRANSCRIPTION FACTOR SP1
    KUMAR, AP
    MAR, PK
    ZHAO, BW
    MONTGOMERY, RL
    KANG, DC
    BUTLER, AP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) : 4341 - 4348
  • [7] Sp1 and Sp3 regulate basal transcription of the survivin gene
    Xu, Rang
    Zhang, Ping
    Huang, Han
    Ge, ShengFang
    Lu, Han
    Qian, GuanXiang
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 356 (01) : 286 - 292
  • [8] CpG site methylation in CRYAA promoter affect transcription factor Sp1 binding in human lens epithelial cells
    Liu, Xin
    Zhou, Peng
    Fan, Fan
    Li, Dan
    Wu, Jihong
    Lu, Yi
    Luo, Yi
    [J]. BMC OPHTHALMOLOGY, 2016, 16
  • [9] CpG site methylation in CRYAA promoter affect transcription factor Sp1 binding in human lens epithelial cells
    Xin Liu
    Peng Zhou
    Fan Fan
    Dan Li
    Jihong Wu
    Yi Lu
    Yi Luo
    [J]. BMC Ophthalmology, 16
  • [10] Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity
    Salowsky, R
    Heiss, NS
    Benner, A
    Wittig, R
    Poustka, A
    [J]. GENE, 2002, 293 (1-2) : 9 - 19